SEQUENZIERUNGSVERFAHREN

Patent europeic · EP4144745 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4144745
Numer da la dumonda
EP21797265
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
30-04-2021
Publitgà
08-03-2023
Concedì
24-12-2025
La protecziun finescha il pli tard
29-04-2041
Proxima taxa annuala scadenta
30-04-2026
Classas IPC
C12Q 1/6874 (2018.01)
G16B 30/20 (2019.01)
G16B 35/10 (2019.01)
G16B 40/20 (2019.01)
Prioritad
CN 202010362587 30.04.2020
CN 202010867569 25.08.2020
CN 202010865293 25.08.2020
Dumonda PCT
PCT/CN2021/091279 30.04.2021
Publicaziun PCT
WO2021/219114 04.11.2021
Lingua da l’annunzia
chinais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 24-12-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 24.12.2025

Partidas

Possessur

GeneMind Biosciences Company Limited

502A, 502B & 602, Podium Building Luohu Investment Holdings Building No. 112 Qingshui River 1st Road Quingshui River Community, Qingshui River Street Luohu District, Shenzhen City, Guangdong 518023, CN

Inventur

FAN, Jicai

Shenzhen, Guangdong 518000, CN

JIN, Huan

Shenzhen, Guangdong 518000, CN

CHEN, Fang

Shenzhen, Guangdong 518000, CN

SUN, Lei

Shenzhen, Guangdong 518000, CN

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.